|
⚲
|
| Keyboard |
| Paul Goddard | |
|---|---|
| Firm | |
| Address | c/o Pathway Therapeutics, Inc 409 Illinois Street San Francisco, CA 94158 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Pathway Therapeutics Inc | 021-192819 | Director | 0.4 M of 0.8 M |
||
| Pathway Therapeutics Inc | 021-187687 | Director | 0.2 M of 0.4 M |
||
| Hemaquest Pharmaceuticals Inc | 021-176133 | Director | 6.5 M of 16.0 M |
||
| AP Pharma Inc /DE/ | 021-162606 | Director | 24.0 M of 24.0 M |
||
| AP Pharma Inc /DE/ | 021-159765 | Director | 1.5 M of 4.5 M |
||
| ARYX Therapeutics Inc | 021-147064 | Executive Officer | 2.0 M of 5.0 M |
||
| Hemaquest Pharmaceuticals | 021-110234 | Director | 16.1 M of 16.1 M |
||
| ARYX Therapeutics Inc | 021-124990 | Executive Officer | 0.4 M of 35.4 M |
||
| AP Pharma Inc /DE/ | 021-26364-LA | Director | 8.1 M of 16.6 M |
||